Screener
Vertex Pharmaceuticals VRTX Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's total revenue?
- Vertex Pharmaceuticals (VRTX) reported total revenue of $3.33B in Q2 2026.
- How has Vertex Pharmaceuticals's total revenue changed year-over-year?
- Vertex Pharmaceuticals's total revenue increased by 12.5% year-over-year, from $2.96B to $3.33B.
- What is the long-term trend for Vertex Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's total revenue has grown at a 12.2% compound annual growth rate (CAGR), from $7.57B to $12B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Vertex Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude